Resona Asset Management Co.,Ltd. Neurocrine Biosciences Inc Transaction History
Resona Asset Management Co.,Ltd.
- $17 Billion
- Q1 2025
A detailed history of Resona Asset Management Co.,Ltd. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Resona Asset Management Co.,Ltd. holds 50,967 shares of NBIX stock, worth $6.35 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
50,967
Previous 49,838
2.27%
Holding current value
$6.35 Million
Previous $6.8 Million
17.14%
% of portfolio
0.03%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding NBIX
# of Institutions
650Shares Held
97.2MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.77 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.24 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$689 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$606 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$333 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...